We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $6.05B
1-Year Est. Return 76.64%
This Fund
S&P 500
This Quarter Est. Return
+12.51%
1 Year Est. Return
+76.64%
3 Year Est. Return
+247.17%
5 Year Est. Return
+285.6%
10 Year Est. Return
+2,546.71%
AUM
$2.72B
AUM Growth
+$313M
Cap. Flow
+$128M
Cap. Flow %
4.71%
Top 10 Hldgs %
27.21%
Holding
156
New
12
Increased
32
Reduced
20
Closed
11

Top Buys

Rank Stock Value
1
SEND
SendGrid, Inc.
SEND
+$62.1M
2
ALTR
Altair Engineering Inc
ALTR
+$38.1M
3
ZGNX
Zogenix, Inc.
ZGNX
+$35.9M
4
SRPT icon
Sarepta Therapeutics
SRPT
+$33.5M
5
ARGX icon
argenx
ARGX
+$20.8M

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$42M
2
SGEN
Seagen Inc. Common Stock
SGEN
+$29.8M
3
W icon
Wayfair
W
+$28.7M
4
IDTI
Integrated Device Technology I
IDTI
+$26.3M
5
ELLI
Ellie Mae Inc
ELLI
+$25.1M

Sector Composition

Rank Sector Weight
1 Healthcare 45.7%
2 Technology 19.3%
3 Consumer Discretionary 10.25%
4 Industrials 6.97%
5 Communication Services 2.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ASND icon
1
Ascendis Pharma A/S
ASND
$16.5B
$109M 4.02%
1,544,900
+157,900
+11% +$10.9M
SRPT icon
2
Sarepta Therapeutics
SRPT
$1.64B
$100M 3.68%
620,000
+245,000
+65% +$33.5M
XPO icon
3
XPO
XPO
$23.4B
$90M 3.3%
2,278,418
– –
SEND
4
DELISTED
SendGrid, Inc.
SEND
$72.4M 2.66%
+1,968,653
New +$62.1M
SAGE
5
DELISTED
Sage Therapeutics
SAGE
$69.8M 2.56%
494,000
+124,000
+34% +$19.1M
LOW icon
6
Lowe's Companies
LOW
$118B
$64.9M 2.38%
565,000
– –
VRTX icon
7
Vertex Pharmaceuticals
VRTX
$122B
$60.3M 2.22%
313,000
+70,000
+29% +$12.5M
W icon
8
Wayfair
W
$11.9B
$59.1M 2.17%
400,000
-226,000
-36% -$28.7M
ZGNX
9
DELISTED
Zogenix, Inc.
ZGNX
$58.7M 2.16%
1,183,792
+705,792
+148% +$35.9M
MYOV
10
DELISTED
Myovant Sciences Ltd.
MYOV
$56.2M 2.06%
2,115,000
+513,339
+32% +$11.6M
SPLK
11
DELISTED
Splunk Inc
SPLK
$54.8M 2.01%
453,000
– –
TTD icon
12
Trade Desk
TTD
$8.59B
$54.3M 2%
3,600,000
– –
VRNS icon
13
Varonis Systems
VRNS
$4.58B
$53.4M 1.96%
2,187,000
+658,416
+43% +$16M
HUBS icon
14
HubSpot
HUBS
$11.9B
$52.8M 1.94%
350,000
– –
AIMT
15
DELISTED
Aimmune Therapeutics
AIMT
$47.4M 1.74%
1,739,000
+119,000
+7% +$3.37M
MIC
16
DELISTED
Macquarie Infrastructure Holdings, LLC
MIC
$47.4M 1.74%
1,028,000
-4,000
-0.4% -$183K
PANW icon
17
Palo Alto Networks
PANW
$265B
$46.9M 1.72%
1,248,000
– –
TECX
18
Tectonic Therapeutic
TECX
$538M
$46.4M 1.7%
77,408
– –
ALTR
19
DELISTED
Altair Engineering Inc
ALTR
$43.5M 1.6%
+1,000,000
New +$38.1M
WCN
20
Waste Connections
WCN
$41.9B
$41.2M 1.51%
517,000
– –
BLUE
21
DELISTED
bluebird bio
BLUE
$40.5M 1.49%
21,431
– –
LOXO
22
DELISTED
Loxo Oncology, Inc
LOXO
$39.1M 1.44%
229,000
– –
FIVN icon
23
FIVE9
FIVN
$2.12B
$39.1M 1.43%
894,000
– –
XIFR
24
XPLR Infrastructure LP
XIFR
$1.12B
$38.8M 1.42%
799,500
-6,500
-0.8% -$309K
OPLN
25
Openlane
OPLN
$4.29B
$36.4M 1.34%
1,611,620
– –
1
2 3 4 5

Similar funds

HPG
Harvest Portfolios Group Oakville, Ontario, Canada $6.06B AUM 16.63% 1-Year Est. Return
EMPI
Elo Mutual Pension Insurance Espoo, Finland $6.06B AUM 24.33% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
JWBC
John W. Bristol & Co New York $6.08B AUM 16.51% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
CIS
Capital International Sarl Los Angeles, California $6.11B AUM 32.29% 1-Year Est. Return

Eventide Asset Management's Q3 2018 Portfolio in Review

As of Q3 2018, Eventide Asset Management held 156 positions worth $2.72B, up 13% from $2.41B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Eventide Asset Management deployed $128M of net new capital in Q3 2018, opening 12 new positions and adding to 32 existing holdings. Its largest new stake was SendGrid, Inc.: 1,968,653 shares worth $72.4M.

By sector, the portfolio is most concentrated in Healthcare at 46% of assets, up from 42% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was AbbVie, an estimated $42M trimmed.

  • Eventide Asset Management's largest Q3 2018 buy was SendGrid, Inc.: 1,968,653 shares worth $72.4M.
  • Eventide Asset Management added most to Zogenix, Inc. in Q3 2018, an estimated $35.9M increase.
  • Eventide Asset Management's biggest Q3 2018 reduction was AbbVie, cutting an estimated $42M.
  • Eventide Asset Management fully exited Integrated Device Technology I in Q3 2018, selling an estimated $26.3M.
  • Eventide Asset Management's ten largest holdings make up 27% of its $2.72B portfolio in Q3 2018.
  • Eventide Asset Management opened 12 new positions and closed 11 in Q3 2018.
  • Eventide Asset Management's portfolio value rose 13% quarter-over-quarter to $2.72B.

Based on Eventide Asset Management's 13F filing for Q3 2018, filed 14 Nov 2018.